SuzukiKIidaOYamauchiY. Impact of diabetes mellitus on critical limb ischemia with below the knee disease—Japan Below-the-knee Artery Treatment (J-BEAT) subanalysis [published online August 21, 2014]. Angiology. 2013. doi: 10.1177/0003319713499606
2.
NorgrenLHiattWRDormandyJANehlerMRHarrisKAFowkesFGR; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67.
3.
StrandnessDEPriestREGibbonsRE. Combined clinical and pathological study of diabetic and non-diabetic peripheral arterial disease. Diabetes. 1964;13(4):366–372.
4.
JudeEBOyiboSOChalmersNBoultonAJ. Peripheral arterial disease in diabetic and non-diabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24(8):1433–1437.
5.
MostRSSinnockP. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care. 1983;6(1):87–91.
6.
KaracagilSAlmgrenBBowaldSBergqvistD. Comparative analysis of patency, limb salvage and survival in diabetic and non-diabetic patients undergoing infrainguinal bypass surgery. Diabetic Med. 1995;12(6):537–541.
7.
BradburyAWAdamDJBellJ. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. Lancet. 2005;366(9501):1925–1934.
8.
National Institute for Health and Care Excellence. Lower Limb Peripheral Arterial Disease (CG147). London: National Institute for Health and Care Excellence; 2012. http://www.nice.org.uk/nicemedia/live/13856/60427/60427.pdf. Accessed June 26, 2013.
9.
DakeMDAnselGMJaffMROhkiTSaxonRRSmouseHB. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomised study results. Circ Cardiovasc Interv. 2011;4(5):495–504.
10.
RastanATepeGKrankenbergHZahorskyRBeschornerUNooryE.Sirolimus eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: A double-blind, multi-centre, randomised clinical trial. Eur Heart J. 2011;32(18):2274–2281.
11.
DudaSHPusichBRichterGLandwehrPOliverVLTielbeekA. Sirolimus-eluting stents for the treatment of obstructive superficial artery disease: six-month results. Circulation. 2002;106(12):1505–1509.
12.
DudaSHBosiersMLammerJScheinertDZellerTOlivaV. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions of the superficial femoral artery: long-term results of the SIROCCO trial. J Endovasc Ther. 2006;13(6):701–710.
13.
DudaSHBosiersMLammerJScheinertDZellerTTielbeekA. Sirolimus-eluting versus bare nitinol stents for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16(3):331–338.
